Literature DB >> 33424767

Disorders of Sex Development in Individuals Harbouring MAMLD1 Variants: WES and Interactome Evidence of Oligogenic Inheritance.

Lele Li1, Fenqi Gao1, Lijun Fan1, Chang Su1, Xuejun Liang1, ChunXiu Gong1.   

Abstract

Mastermind-like domain-containing 1 (MAMLD1) has been shown to play an important role in the process of sexual development and is associated with 46,XY disorders of sex development (DSDs). However, the causative role of MAMLD1 variations in DSDs remains disputable. In this study, we have described a clinical series on children from unrelated families with 46,XY DSD harbouring MAMLD1 variants. Whole exome sequencing (WES) was performed for each patient. WES data were filtered using common tools and disease customisation algorithms, including comparison against lists of known and candidate MAMLD1-related and DSD-related genes. Lastly, we investigated the hypothesis that MAMLD1-related DSD may follow an oligogenic mode of inheritance. Forty-three potentially deleterious/candidate variants of 18 genes (RET, CDH23, MYO7A, NOTCH2, MAML1, MAML2, CYP1A1, WNT9B, GLI2, GLI3, MAML3, WNT9A, FRAS1, PIK3R3, FREM2, PTPN11, EVC, and FLNA) were identified, which may have contributed to the patient phenotypes. MYO7A was the most commonly identified gene. Specific gene combinations were also identified. In the interactome analysis, MAMLD1 exhibited direct connection with MAML1/2/3 and NOTCH1/2. Through NOTCH1/2, the following eight genes were shown to be associated with MAMLD1:WNT9A/9B, GLI2/3, RET, FLNA, PTPN11, and EYA1. Our findings provide further evidence that individuals with MAMLD1-related 46,XY DSD could carry two or more variants of known DSD-related genes, and the phenotypic outcome of affected individuals might be determined by multiple genes.
Copyright © 2020 Li, Gao, Fan, Su, Liang and Gong.

Entities:  

Keywords:  MAMLD1; disorders of sexual development; hypospadias; oligogenic inheritance; whole exome sequencing

Year:  2020        PMID: 33424767      PMCID: PMC7786837          DOI: 10.3389/fendo.2020.582516

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  38 in total

1.  A novel hemizygous mutation of MAMLD1 in a patient with 46,XY complete gonadal dysgenesis.

Authors:  Inge-Lore Ruiz-Arana; Angela Hübner; Cigdem Cetingdag; Heiko Krude; Annette Grüters; Maki Fukami; Heike Biebermann; Birgit Köhler
Journal:  Sex Dev       Date:  2015-02-03       Impact factor: 1.824

Review 2.  Signaling Pathways Involved in Mammalian Sex Determination and Gonad Development.

Authors:  Simon P Windley; Dagmar Wilhelm
Journal:  Sex Dev       Date:  2016-02-24       Impact factor: 1.824

3.  Mutational study of the MAMLD1-gene in hypospadias.

Authors:  Yougen Chen; Hanh T T Thai; Johanna Lundin; Kristina Lagerstedt-Robinson; Shengtian Zhao; Ellen Markljung; Agneta Nordenskjöld
Journal:  Eur J Med Genet       Date:  2010-03-25       Impact factor: 2.708

Review 4.  Gene mutations associated with anomalies of human gonad formation.

Authors:  A Bashamboo; K McElreavey
Journal:  Sex Dev       Date:  2012-10-03       Impact factor: 1.824

Review 5.  Beyond the One Gene-One Disease Paradigm: Complex Genetics and Pleiotropy in Inheritable Cardiac Disorders

Authors:  Marina Cerrone; Carol Ann Remme; Rafik Tadros; Connie R Bezzina; Mario Delmar
Journal:  Circulation       Date:  2019-08-12       Impact factor: 29.690

Review 6.  Emerging roles of Notch signaling in liver disease.

Authors:  Fabian Geisler; Mario Strazzabosco
Journal:  Hepatology       Date:  2014-09-19       Impact factor: 17.425

7.  Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence.

Authors:  Maki Fukami; Yuka Wada; Michiyo Okada; Fumiko Kato; Noriyuki Katsumata; Takashi Baba; Ken-ichirou Morohashi; Jocelyn Laporte; Motoo Kitagawa; Tsutomu Ogata
Journal:  J Biol Chem       Date:  2007-12-27       Impact factor: 5.157

Review 8.  Common vs. rare allele hypotheses for complex diseases.

Authors:  Nicholas J Schork; Sarah S Murray; Kelly A Frazer; Eric J Topol
Journal:  Curr Opin Genet Dev       Date:  2009-05-28       Impact factor: 5.578

Review 9.  Genetic regulation of mammalian gonad development.

Authors:  Stefanie Eggers; Thomas Ohnesorg; Andrew Sinclair
Journal:  Nat Rev Endocrinol       Date:  2014-09-23       Impact factor: 43.330

10.  Resolution of Disease Phenotypes Resulting from Multilocus Genomic Variation.

Authors:  Jennifer E Posey; Tamar Harel; Pengfei Liu; Jill A Rosenfeld; Regis A James; Zeynep H Coban Akdemir; Magdalena Walkiewicz; Weimin Bi; Rui Xiao; Yan Ding; Fan Xia; Arthur L Beaudet; Donna M Muzny; Richard A Gibbs; Eric Boerwinkle; Christine M Eng; V Reid Sutton; Chad A Shaw; Sharon E Plon; Yaping Yang; James R Lupski
Journal:  N Engl J Med       Date:  2016-12-07       Impact factor: 91.245

View more
  3 in total

1.  A New MAMLD1 Variant in an Infant With Microphallus and Hypospadias With Hormonal Pattern Suggesting Partial Hypogonadotropic Hypogonadism-Case Report.

Authors:  Diego Yeste; Cristina Aguilar-Riera; Gennaro Canestrino; Paula Fernández-Alvarez; María Clemente; Núria Camats-Tarruella
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-28       Impact factor: 6.055

2.  A systematic review of the validated monogenic causes of human male infertility: 2020 update and a discussion of emerging gene-disease relationships.

Authors:  Brendan J Houston; Antoni Riera-Escamilla; Margot J Wyrwoll; Albert Salas-Huetos; Miguel J Xavier; Liina Nagirnaja; Corinna Friedrich; Don F Conrad; Kenneth I Aston; Csilla Krausz; Frank Tüttelmann; Moira K O'Bryan; Joris A Veltman; Manon S Oud
Journal:  Hum Reprod Update       Date:  2021-12-21       Impact factor: 15.610

3.  An earphone wire inside the urinary bladder: A case report and comprehensive literature review of genitourinary polyembolokoilamania.

Authors:  Haviv Muris Saputra; Yudhistira Pradnyan Kloping; Johan Renaldo; Lukman Hakim
Journal:  Radiol Case Rep       Date:  2022-03-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.